Lv41
800 积分 2026-04-30 加入
The evolving landscape of drug targets
13天前
已完结
The evolving landscape of drug targets
16天前
已完结
Optimization of lipid nanoparticle components and microfluidic parameters for intramuscular circRNA delivery with reduced hepatic off-targeting
1个月前
已完结
An inherent T cell‑activating mRNA delivery carrier for in vivo CAR T generation
1个月前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
2个月前
已完结